Decker, NJ
Kate Delano-Condax Decker, Moorestown, NJ US
Patent application number | Description | Published |
---|---|---|
20140039421 | Method for Treating Poison Ivy and Similar Poison Plant Induced Rashes - A method for treating poison ivy and similar poison plant induced rashes utilizes a sealed pouch containing a mixture of anti-inflammatory, analgesic, and anti-oxidant property ingredients. The pouch is placed in a container filled with boiling water. The ingredients in the pouch permeate through the water. A metal applicator has a spoon-shaped section with a curved lower surface and a handle. The spoon-shaped section is inserted into the boiled herbal water mixture. The bottom surface of the curved lower surface of the spoon-shaped section is then momentarily placed on the pustule or red bump of the poison ivy. The applicator is then lifted up away from the area. Usually two or three touches with the applicator on the effected area will completely remove the itching and the itching and pustule will be entirely eliminated within twenty-four to forty-eight hours. | 02-06-2014 |
Randall T. Decker, Hillsborough, NJ US
Patent application number | Description | Published |
---|---|---|
20150106286 | Performance, Productivity And Efficiency Planning For Employee Relocation Program Effectiveness - A method of employee relocation program planning designed to maximize program effectiveness through the assessment of benefit performance, benefit efficiency, and employee productivity to internal and external groups, and the defining of principles and methodologies. Employee surveys capture satisfaction responses for counseling, services, and benefit effectiveness, and employee perception of benefit importance and program expectations. Survey results are calculated to produce performance, productivity and efficiency scores; whereto program-balancing principles and methodologies are applied to increase program effectiveness. Computerized applications collect, store and calculate data, and includes tools programmed to dynamically model performance balancing scenarios for achieving desired outcomes. Additional functionality applies productivity outputs against comparable variables for analyses of alternate company programs, including talent mobility planning, return on investment and cost management. | 04-16-2015 |
Ronald Decker, Tumersville, NJ US
Patent application number | Description | Published |
---|---|---|
20120290145 | Single-stage grid-connected solar inverter for distributed reactive power generation - The present invention proposes a method and a system for generating a bidirectional power flow between a DC component and an AC grid for a distributed power generation system using solar panels. The system includes an inverter that further includes a DC component for generating DC power and a single-stage DC-AC converter for converting the DC power into AC power by operating in one or more pre-defined modes. The AC power includes a reactive power component and an active power component. | 11-15-2012 |
Ronald Decker, Turnersville, NJ US
Patent application number | Description | Published |
---|---|---|
20140266728 | ELECTRONIC ARTICLE SURVEILLANCE PORTAL - A system and device for detecting and/or deactivating a security tag when passing through an electronic article surveillance (EAS) portal. The portal may be oriented by the arrangement of one or more antennas to generate an electromagnetic field at or within the portal to detect and/or deactivate the security tag. The electromagnetic field may detect and/or deactivate a security tag located at any orientation on merchandise as the security tag passes through the portal. The portal may be mounted on a counter at a point-of-sale station in which merchandise having security tags attached thereto are passed through the portal. The portal may also be mounted to a floor in which a shopping cart having merchandise is passed through the portal so that security tags attached to the merchandise in the cart are detected and/or deactivated. | 09-18-2014 |
Ronald A. Decker, Turnersville, NJ US
Patent application number | Description | Published |
---|---|---|
20130276883 | ROTATABLE MOUNTING SYSTEM - A rotatable assembly for supporting a fixture from a structure may be provided. The rotatable assembly may comprise a mounting bracket and a support arm rotatably attached to the mounting bracket. The support arm may have a connection point for receiving the fixture. | 10-24-2013 |
Stefanie Decker, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20090035343 | DELIVERY OF DRY FORMULATIONS OF OCTREOTIDE - Methods and devices are described for delivering octreotide to a patient, comprising implanting a controlled release composition for delivering octreotide, wherein the composition does not require hydration prior to implantation, and wherein the composition optionally comprises a release agent. | 02-05-2009 |
20100021522 | SUSTAINED DELIVERY OF EXENATIDE AND OTHER PEPTIDES - Described herein are implantable devices, formulations and methods of making implantable devices for the release of a polypeptide from an implantable device, and methods of use thereof. | 01-28-2010 |
20100022450 | OCTREOTIDE IMPLANT HAVING A RELEASE AGENT - Methods, formulations and kits are described that allow for the controlled release of octreotide, e.g., octreotide acetate, in a subject. | 01-28-2010 |
20100247594 | DELIVERY OF DRY FORMULATIONS OF OCTREOTIDE - Methods and devices are described for delivering octreotide to a patient, comprising implanting a controlled release composition for delivering octreotide, wherein the composition does not require hydration prior to implantation, and wherein the composition optionally comprises a release agent. | 09-30-2010 |
20100292144 | SUSTAINED DELIVERY OF EXENATIDE AND OTHER PEPTIDES - Described herein are implantable devices, formulations and methods of making implantable devices for the release of a polypeptide from an implantable device, and methods of use thereof. | 11-18-2010 |
20110009338 | CONTROLLED RELEASE FORMULATIONS OF OCTREOTIDE - A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decreasing IGF-1, and treating conditions associated with carcinoid tumors and VIPomas by administering a controlled release formulation of octreotide are provided herein. | 01-13-2011 |
20110206745 | OCTREOTIDE IMPLANT HAVING A RELEASE AGENT - Methods, formulations and kits are described that allow for the controlled release of octreotide, e.g., octreotide acetate, in a subject. | 08-25-2011 |
20130115264 | IMPLANTABLE RASAGILINE COMPOSITIONS AND METHODS OF TREATMENT THEREOF - A method of treating the symptoms of Parkinson's disease comprises implanting a reservoir-based drug delivery composition into a subject to systemically deliver a therapeutically effective amount of rasagiline to the subject for a long period of time (e.g., one month or one year). The drug delivery composition may include a rate-controlling excipient (e.g., an elastomeric polymer) defining a reservoir containing at least one discrete solid dosage form (e.g., one or more pellets), which includes rasagiline hemitartrate and optionally, a sorption enhancer. | 05-09-2013 |
20130252894 | SUSTAINED DELIVERY OF EXENATIDE AND OTHER POLYPEPTIDES - Described herein are implantable devices, formulations and methods of making implantable devices for the release of a polypeptide from an implantable device, and methods of use thereof. | 09-26-2013 |
Stephanie Decker, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20080311170 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME - Medical implant devices are prepared from a polymeric material and a release agent, where the device is a molded, reservoir implant, and the release agent has a molecular weight (MW) of at least 1000. The release agent may be a non-ionic surfactant such as Brij 35, polyoxyetheylene(20)sorbitan trioleate, Tween 20, Tween 80, vitamin E TPGS, and a mixture of any two or more thereof. Hydrated implants may have a surface area of about 500 mm | 12-18-2008 |
20090087470 | CONTROLLED RELEASE FORMULATIONS OF OCTREOTIDE - A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decreasing IGF-1, and treating conditions associated with carcinoid tumors and VIPomas by administering a controlled release formulation of octreotide are provided herein. | 04-02-2009 |
20100317579 | CONTROLLED RELEASE FORMULATIONS OF OCTREOTIDE - A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decreasing IGF-1, and treating conditions associated with carcinoid tumors and VIPomas by administering a controlled release formulation of octreotide are provided herein. | 12-16-2010 |
Thomas R. Decker, Bloombury, NJ US
Patent application number | Description | Published |
---|---|---|
20130317766 | Sediment Monitoring System for Stormwater Management Facilities - A dual sensor sediment monitoring system for stormwater management facilities comprises a capacitive sensor and an ultrasonic sensor. The former periodically determines if a liquid layer exists above the sediment and activates the ultrasonic sensor when it does not. The echo delay measured by the ultrasonic sensor is used to calculate the sediment level, which is wirelessly transmitted to a remote computer for database compilation and use in scheduling maintenance involving sediment removal. | 11-28-2013 |